Thu.Oct 15, 2020

Should you include your sweat equity in a business plan?

Berkonomics

Investors love it when entrepreneurs draw little or no money from their startups. It extends the cash available for research and other necessary fixed costs and gives the fragile, young company more “runway” to get to breakeven. What are you worth to the business?

Equity 156

IDrive Targets Businesses With New Video Conferencing Tool

socalTECH

Los Angeles-based online backup and storage provider IDrive Online Backup says it has released a new service, which provides secure video conferencing. According to IDrive, its new tool, EPYC, offers both secure video conferencing and "AR" capability for remote workforces. The company said it launched the new tool as a result of COVID-19 and the current remote work climate.

Tool 109

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

RayzeBio Finds $45M For Cancer Therapeutics

socalTECH

San Diego-based RayzeBio , which is working on using radioactive materials to treat cancer, said this week that it has raised $45M for its cancer therapeutics efforts. The Series A funding was led by venBio Partners and Versant Ventures, and also included Samsara BioCapital. The company said the funding will go to advance its development of a pipeline of targeted radiopharmaceuticals for cancer therapeutics. The company's products are centered around the radioactive material Actinium-225.

AlphaTrAI Applies AI To Investment Management

socalTECH

San Diego-based AlphaTrAI , a fintech startup which is backed by venture capital investor Analytics Ventures, says it is launching its own, extrenal fund, and is expanding its leadership team.

Invest 100

Can You Ask for Office Rent Relief? How to Manage Your Lease During COVID-19

Office leases are one of companies’ largest expenses, and if your whole team is working from home with no clear end in sight, you may be wondering what to do about your lease.

Evofem Biosciences Scores $25M

socalTECH

San Diego-based Evofem Biosciences , a biopharmaceuticals firm which is developing products to prevent urogenital chlamydia and gonorrhea in women, and which also markets a vaginal contraceptive gel, saysi t has raised $25M in a strategic investment. The publicly held company--which trades on the NASDAQ as EVFM--said the investment came via unsecured convertible promissory notes. The investment came from Adjuvant Capital.